Economic Burden of Fungal Diseases in the United States
Kaitlin Benedict, Hilary K. Whitham, Brendan R. Jackson
Abstract
We conservatively estimated the US economic burden of fungal diseases as $11.5 billion in 2019: direct medical costs ($7.5 billion), productivity loss due to absenteeism ($870 million), and premature deaths ($3.2 billion). An alternative "value of statistical life" approach yielded >$48 billion. These are likely underestimates given underdiagnosis and underreporting.
Topics & Concepts
MedicineAbsenteeismEnvironmental healthEconomicsManagementAntifungal resistance and susceptibilityPlant Pathogens and Fungal DiseasesEntomopathogenic Microorganisms in Pest Control